Studying How Enhanced Recovery After Surgery ERAS and Multimodal Pain Relief Affect Hospital Stay Length After Elective Laparoscopic Gynecological Surgeries

What this Trial Is About

Researchers are studying the impact of multimodal analgesia with or without the Enhanced Recovery After Surgery ERAS protocol on the length of hospital stay in female patients undergoing elective laparoscopic gynecological surgeries. This Phase 4 randomized trial aims to better understand how these approaches affect recovery times after surgery. Participants receive either the ERAS protocol or a control treatment. The ERAS protocol involves specific preoperative steps such as carbohydrate drinks and medication before surgery, followed by intravenous lidocaine and fentanyl during the procedure. The control group receives standard preoperative fasting and a different pain medication during surgery. The study compares these two approaches to see how they influence hospital stay length and recovery. During the study, researchers will measure the length of hospital stay from recovery room arrival until 72 hours after surgery. They will also assess pain levels at several time points after surgery, track opioid use, and evaluate patient satisfaction one day post-operation. Participants are monitored closely throughout the hospital stay to collect data on recovery experience and medication use.

Impact of ERAS Protocol on Length of Hospital Stay After Laparoscopic Surgeries